|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 243.45 USD | -0.45% |
|
+1.44% | +17.64% |
Chart calendar Johnson & Johnson
Upcoming events on Johnson & Johnson
| 2026-02-23 | Add to your calendar Google Apple ICS format | |
| 2026-03-03 | TD Cowen Health Care Conference | Add to your calendar Google Apple ICS format |
| 2026-03-10 | Barclays Global Healthcare Conference | Add to your calendar Google Apple ICS format |
| 2026-04-13 | Q1 2026 Earnings Release | Add to your calendar Google Apple ICS format |
| 2026-07-21 | Q2 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 2026-10-19 | Q3 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 2027-01-25 | Q4 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 2027-04-19 | Q1 2027 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
Past events on Johnson & Johnson
| 2026-01-21 | Q4 2025 Earnings Call |
| 2026-01-21 | Q4 2025 Earnings Release |
| 2026-01-12 | J.P. Morgan Healthcare Conference |
| 2025-12-05 | American Society of Hematology Meeting - Oral #568 |
| 2025-12-05 | American Society of Hematology Meeting - Poster #5200 |
| 2025-12-05 | American Society of Hematology Meeting - Poster #5199 |
| 2025-12-05 | American Society of Hematology Meeting - Poster #3301 |
| 2025-12-05 | American Society of Hematology Meeting - Plenary Scientific Session Abstract #1 |
| 2025-12-05 | American Society of Hematology Meeting - Poster #4569 |
| 2025-12-05 | American Society of Hematology Meeting - Poster #3934 |
| 2025-12-05 | American Society of Hematology Meeting - Poster #4054 |
| 2025-12-05 | American Society of Hematology Meeting - Poster #4042 |
| 2025-12-05 | American Society of Hematology Meeting - Poster #5821 |
| 2025-12-05 | American Society of Hematology Meeting - Poster #2282 |
| 2025-12-05 | American Society of Hematology Meeting - Oral #701 |
| 2025-12-05 | American Society of Hematology Meeting - Oral #698 |
| 2025-12-05 | American Society of Hematology Meeting - Oral #372 |
| 2025-12-05 | American Society of Hematology Meeting - Oral #691 |
| 2025-12-05 | American Society of Hematology Meeting - Oral #97 |
| 2025-12-05 | American Society of Hematology Meeting - Oral #92 |
Past dividends on Johnson & Johnson
| 2025-11-24 | Quarterly 1.3 USD |
| 2025-08-25 | Quarterly 1.3 USD |
| 2025-05-26 | Quarterly 1.3 USD |
| 2025-02-17 | Quarterly 1.24 USD |
| 2024-11-25 | Quarterly 1.24 USD |
| 2024-08-26 | Quarterly 1.24 USD |
| 2024-05-19 | Quarterly 1.24 USD |
| 2024-02-15 | Quarterly 1.19 USD |
| 2023-11-19 | Quarterly 1.19 USD |
| 2023-08-24 | Quarterly 1.19 USD |
| 2023-05-21 | Quarterly 1.19 USD |
| 2023-02-16 | Quarterly 1.13 USD |
| 2022-11-20 | Quarterly 1.13 USD |
| 2022-08-21 | Quarterly 1.13 USD |
| 2022-05-22 | Quarterly 1.13 USD |
| 2022-02-17 | Quarterly 1.06 USD |
| 2021-11-21 | Quarterly 1.06 USD |
| 2021-08-22 | Quarterly 1.06 USD |
| 2021-05-23 | Quarterly 1.06 USD |
| 2021-02-21 | Quarterly 1.01 USD |
Annual results
| Fiscal Period | December | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 94 943 95 017 -0.08% | 85 159 84 764 0.47% | 88 821 88 765 0.06% | 94 193 93 759 0.46% | 100 581 | 105 759 |
|
EBITDA Million USD | Released Forecast Spread | 32 630 32 564 0.2% | 30 414 31 998 -4.95% | 29 288 30 409 -3.69% | 0,00 33 741 - | 36 932 | 39 361 |
|
EBIT Million USD | Released Forecast Spread | 29 965 29 608 1.21% | 27 460 27 881 -1.51% | 26 466 26 967 -1.86% | 30 358 30 751 -1.28% | 33 472 | 35 875 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 21 725 25 756 -15.65% | 15 062 20 454 -26.36% | 16 687 20 759 -19.61% | 32 581 28 661 13.68% | 28 917 | 28 991 |
|
Net income Million USD | Released Forecast Spread | 17 941 20 668 -13.19% | 35 153 19 696 78.48% | 14 066 17 495 -19.6% | 26 804 26 504 1.13% | 23 635 | 25 199 |
|
EPS USD | Released Forecast Spread | 6,73 7,95 -15.29% | 13,7 8,44 62.56% | 5,79 6,93 -16.39% | 11,0 11,0 0.19% | 9,82 | 10,6 |
| Announcement Date | 24/01/23 | 23/01/24 | 22/01/25 | 21/01/26 |
Quarterly results
| Fiscal Period | September | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 21 383 21 386 -0.01% | 22 447 22 337 0.49% | 22 471 22 171 1.35% | 22 520 22 436 0.38% | 21 893 21 562 1.54% | 23 743 22 861 3.86% | 23 993 23 755 1% | 24 564 24 149 1.72% | 23 600 | 25 063 | 25 327 | 26 566 | 24 498 | 26 363 | 26 752 |
|
EBITDA Million USD | Released Forecast Spread | 7 973 7 747 2.92% | 8 388 8 129 3.18% | 7 164 7 063 1.43% | 5 763 6 223 -7.4% | 8 037 8 385 -4.15% | 8 637 8 279 4.32% | 8 897 8 583 3.65% | 8 086 | 8 696 | 9 128 | 9 537 | 9 311 | 9 367 | 9 871 | 10 217 |
|
EBIT Million USD | Released Forecast Spread | 7 236 7 203 0.46% | 7 712 7 433 3.76% | 6 489 6 085 6.63% | 5 029 5 471 -8.08% | 7 385 7 290 1.31% | 7 961 7 605 4.68% | 8 168 7 998 2.13% | 6 844 7 196 -4.9% | 7 831 | 8 374 | 8 734 | 8 536 | 8 354 | 9 033 | 9 248 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 6 440 6 329 1.75% | 5 748 6 910 -16.82% | 3 338 4 923 -32.2% | 3 887 4 591 -15.33% | 13 631 5 447 150.25% | 6 491 6 600 -1.65% | 7 493 6 441 16.34% | 4 966 6 062 -18.08% | 6 671 | 7 282 | 7 571 | 7 438 | |||
|
Net income Million USD | Released Forecast Spread | 5 354 5 293 1.15% | 4 686 5 093 -8% | 2 694 4 083 -34.02% | 3 431 4 240 -19.08% | 10 999 5 229 110.34% | 5 537 5 262 5.23% | 5 152 5 809 -11.3% | 5 116 5 515 -7.23% | 5 654 | 5 931 | 6 184 | 5 867 | |||
|
EPS USD | Released Forecast Spread | 2,20 2,21 -0.57% | 1,93 2,09 -7.72% | 1,11 1,69 -34.13% | 1,41 1,78 -20.69% | 4,54 2,26 100.92% | 2,29 2,18 5.05% | 2,12 2,29 -7.22% | 2,10 2,19 -4% | 2,27 | 2,50 | 2,58 | 2,42 | 2,47 | 2,74 | 2,77 |
| Announcement Date | 16/04/24 | 17/07/24 | 15/10/24 | 22/01/25 | 15/04/25 | 16/07/25 | 14/10/25 | 21/01/26 | - | - | - | - | - | - | - |
| 2026-02-17 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format | |
| 2026-02-17 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 2026-02-18 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 2026-02-18 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 2026-02-18 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 2026-02-19 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format | |
| 2026-02-19 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format | |
| 2026-02-19 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 2026-02-20 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format | |
| 2026-02-22 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format |
Past sector events for Johnson & Johnson
| 2026-02-13 | Q3 2026 Earnings Release | |
| 2026-02-12 | Q3 2026 Earnings Release | |
| 2026-02-12 | Q3 2026 Earnings Release | |
| 2026-02-12 | Q3 2026 Earnings Release | |
| 2026-02-12 | Q3 2026 Earnings Release | |
| 2026-02-12 | Q3 2026 Earnings Release | |
| 2026-02-12 | Q3 2025 Earnings Release | |
| 2026-02-12 | Q3 2025 Earnings Release | |
| 2026-02-12 | Q4 2025 Earnings Release | |
| 2026-02-12 | Q4 2025 Earnings Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- JNJ Stock
- Calendar Johnson & Johnson
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















